Preclinical antibody approach aims to treat type 1 diabetes at its immune source

1 month ago 8
Seven years ago, Johns Hopkins researchers and their collaborators announced they had recovered the X cell, a caller immune compartment that plays a cardinal relation successful the improvement of benignant 1 diabetes.
Read Entire Article